🟢 Indaptus Therapeutics is trading 5.46% up

Indaptus Therapeutics is trading at $2.51, up 5.46%, with no verified catalyst identified for the move.

• No verified company announcement or confirmed catalyst explaining the move was found for October 5, 2026; available company-news listings show no new release that day.
• The broader market was higher, with the S&P 500 up 0.66% and Nasdaq up 1.15%, but available evidence does not establish that this drove Indaptus Therapeutics’ gain.
• Provided price context shows a rebound after recent declines; reliable price data provided does not establish volume or other trading-activity details.